Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Dalgard

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Plos One|July 14, 2017
Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life studyOlav Dalgard, Ola Weiland, Geir Noraberg, et al.
Journal of Hepatology|January 19, 2016
Hepatitis C reinfection after sustained virological responseHåvard Midgard, Benedikte Bjøro, Arild Mæland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2018
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems frameworkEmma Day, Margaret Hellard, Carla Treloar, et al.
Journal of Addictive Diseases|August 3, 2022
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infectionOlav Dalgard, Alain H Litwin, Oren Shibolet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE studyHåvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Plos One|July 14, 2017
Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life studyOlav Dalgard, Ola Weiland, Geir Noraberg, et al.
Journal of Hepatology|January 19, 2016
Hepatitis C reinfection after sustained virological responseHåvard Midgard, Benedikte Bjøro, Arild Mæland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2018
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems frameworkEmma Day, Margaret Hellard, Carla Treloar, et al.
Journal of Addictive Diseases|August 3, 2022
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infectionOlav Dalgard, Alain H Litwin, Oren Shibolet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE studyHåvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
Pageof 11